trending Market Intelligence /marketintelligence/en/news-insights/trending/7gu-dxa_uuv2fqoinptpaq2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Ritter Pharmaceuticals implements 1-for-10 reverse stock split

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Ritter Pharmaceuticals implements 1-for-10 reverse stock split

Los Angeles-based Ritter Pharmaceuticals Inc. implemented a 1-for-10 reverse split of its common stock, effective March 23.

The split will reduce Ritter's issued and outstanding common shares to 4,940,652 from 49,406,521.

Corporate Stock Transfer Inc. is acting as exchange agent for the split.